In its debut trading on Friday, May 7 Talaris Therapeutics, Inc. (TALS) showed a 4,41% decrease and by the end of trading closed at $16.25. Shortly before the company had placed its shares in an IPO at a price of $17 per share.
Заполните форму и наш специалист свяжется с вами в ближайшее время для уточнения деталей